2,023
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 1803530 | Received 23 Mar 2020, Accepted 18 Jul 2020, Published online: 20 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chao-Chih Wu, Yun-Ting Hsu & Chih-Long Chang. (2021) Hyperthermic intraperitoneal chemotherapy enhances antitumor effects on ovarian cancer through immune-mediated cancer stem cell targeting. International Journal of Hyperthermia 38:1, pages 1013-1022.
Read now

Articles from other publishers (12)

Xukai Luo, Jiahang Mo, Min Zhang, Wu Huang, Yiting Bao, Ruoyao Zou, Liangqing Yao & Lei Yuan. (2024) CD47—a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features. World Journal of Surgical Oncology 22:1.
Crossref
Timothy N. Trotter, Carina E. Dagotto, Delila Serra, Tao Wang, Xiao Yang, Chaitanya R. Acharya, Junping Wei, Gangjun Lei, H. Kim Lyerly & Zachary C. Hartman. (2023) Dormant tumors circumvent tumor-specific adaptive immunity by establishing a Treg-dominated niche via DKK3. JCI Insight 8:22.
Crossref
Yu'e Liu, Linjun Weng, Yanjin Wang, Jin Zhang, Qi Wu, Pengcheng Zhao, Yufeng Shi, Ping Wang & Lan Fang. (2023) Deciphering the role of CD47 in cancer immunotherapy. Journal of Advanced Research.
Crossref
David Sebben, Gisela Strohle, Promit Sinha Roy & Huiyan Li. (2023) Gold-nanoparticle-embedded hydrogel droplets with enhanced fluorescence for imaging and quantification of proteins in cells. Microchimica Acta 190:4.
Crossref
Ayse Sedef Köseer, Simona Di Gaetano, Claudia Arndt, Michael Bachmann & Anna Dubrovska. (2023) Immunotargeting of Cancer Stem Cells. Cancers 15:5, pages 1608.
Crossref
Trevor G. Shepherd & Frederick A. Dick. (2022) Principles of dormancy evident in high-grade serous ovarian cancer. Cell Division 17:1.
Crossref
Jing Ding, Yan Zhang & Yan Che. (2022) Ovarian cancer stem cells: Critical roles in anti-tumor immunity. Frontiers in Genetics 13.
Crossref
Yuan Fang, Ting Zhong, Lishou Yang, Fang Luo, Qing Li, Daoping Wang, Qiji Li, Yanhua Fan & Xiaosheng Yang. (2022) Spiropachysine A suppresses hepatocellular carcinoma proliferation by inducing methuosis in vitro and in vivo. Phytomedicine 102, pages 154151.
Crossref
Weihong Lu, Fei Zhang, Xiaolin Zhong, Jinhua Wei, Hongyang Xiao & Ruiqin Tu. (2022) Immune Subtypes Characterization Identifies Clinical Prognosis, Tumor Microenvironment Infiltration, and Immune Response in Ovarian Cancer. Frontiers in Molecular Biosciences 9.
Crossref
Jacek R Wilczyński, Miłosz Wilczyński & Edyta Paradowska. (2022) Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies. International Journal of Molecular Sciences 23:5, pages 2496.
Crossref
Lan Yu, Yi Ding, Ting Wan, Ting Deng, He Huang & Jihong Liu. (2021) Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer. Frontiers in Immunology 12.
Crossref
Parth M. Patel, Margaret R. Connolly, Taylor M. Coe, Anthony Calhoun, Franziska Pollok, James F. Markmann, Lars Burdorf, Agnes Azimzadeh, Joren C. Madsen & Richard N. PiersonIIIIII. (2021) Minimizing Ischemia Reperfusion Injury in Xenotransplantation. Frontiers in Immunology 12.
Crossref